Zymergen Inc., a biofacturing company, announced the appointments of Subodh Deshmukh as Chief Development Officer and Lincoln Germain as Chief Commercial Officer.
Subodh Deshmukh, Chief Development Officer, brings more than 20 years of experience across all stages of product development, from research to engineering and launch management at global scale. He most recently served as Global Head of Product Development for Sandoz, the $10 billion generics division of Novartis, and previously held technical and executive leadership positions with Sun Pharma, Pfizer and Bristol-Myers Squibb.
As Chief Development Officer, Deshmukh will oversee Zymergen’s product development process to ensure the robustness of the Company’s pipeline.
Lincoln Germain, Chief Commercial Officer, brings more than 25 years of experience in senior positions at multinational materials, agrochemical and consumer packaged goods corporations, most recently serving as Vice President and Chief Commercial Officer at Honeywell International’s $3 billion Advanced Materials business.
As Zymergen’s Chief Commercial Officer, Germain will lead the rebuilding of the Company’s commercial team, increasing the robustness of our market and customer value discovery analysis, and establishing a reliable sales pipeline qualification and forecasting process.
“We are pleased to welcome Lincoln and Subodh to the Zymergen team as we continue enhancing our leadership team and position Zymergen as a stronger company with a disciplined plan for growth and value creation,” said Jay Flatley, Acting CEO and Chairman of the Board. “Both Lincoln and Subodh are seasoned executives, and their significant experience and expertise will be invaluable as we move forward. Alongside Aindrea Campbell, who was appointed Chief Manufacturing Officer in May, these appointments will reinforce our strong focus on operations and advance our goal of developing and delivering breakthrough products to the market.”
Germain commented, “Zymergen has immense potential to solve the world’s biggest problems through its unique integration of genomics, machine learning and automation. I look forward to working with the rest of the team to build a commercial organization that understands its customers and end users, so that we can consistently deliver the innovative products and solutions they need to create substantial value.”
“Like my new colleagues at Zymergen, I am passionate about pushing scientific boundaries and fundamentally changing how materials are made and what they are made of,” Deshmukh added. “I’m honored to work with the innovative team at Zymergen to design and manufacture powerful products based on nature’s own inventions that meet market needs.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.